spironolactone has been researched along with imidazolidines in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Namer, M | 1 |
Kobayashi, N; Matsuoka, H; Nakano, S; Ohno, T; Yoshida, K | 1 |
Hoshi, T; Iida, K; Kawano, S; Masumi, T; Misaki, M; Nishi, I; Watanabe, S; Yamaguchi, I | 1 |
Anker, SD; Argiles, JM; Beadle, J; Coats, AJ; Doehner, W; Földes, G; Force, T; Grzesiak, A; Haghikia, A; Hilfiker-Kleiner, D; Hocher, B; Jaisser, F; Kaschina, E; Lal, H; Latouche, C; Morawietz, L; Palus, S; Pötsch, M; Springer, J; Thum, T; Tschirner, A; von Haehling, S; von Websky, K | 1 |
Barbon, AR; Barrows, M; Borgeat, K; Day, C; Drane, AL; Hayward, N; Killick, R; Naylor, A; Routh, A; Saunders, R; Sewell, D; Studies, PGCEA; Wilkie, L | 1 |
1 review(s) available for spironolactone and imidazolidines
Article | Year |
---|---|
Clinical applications of antiandrogens.
Topics: Androgen Antagonists; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Puberty, Precocious; Skin Diseases; Spironolactone | 1988 |
4 other study(ies) available for spironolactone and imidazolidines
Article | Year |
---|---|
Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinas
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemokine CCL2; Coronary Vessels; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibrillar Collagens; Gene Expression; Heart Ventricles; Hypertension; Imidazolidines; Intracellular Signaling Peptides and Proteins; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Peptidyl-Dipeptidase A; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Scavenger Receptors, Class E; Signal Transduction; Sodium Chloride; Spironolactone; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Addition of spironolactone to an angiotensin-converting enzyme inhibitor decreases lung congestion and edema in Dahl hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Drug Therapy, Combination; Hypertension; Imidazolidines; Male; Mineralocorticoid Receptor Antagonists; Pulmonary Edema; Rats; Rats, Inbred Dahl; Spironolactone | 2006 |
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bisoprolol; Body Composition; Body Weight; Cachexia; Glycogen Synthase Kinase 3; Heart Failure; Imidazolidines; Liver Neoplasms; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Myosin Heavy Chains; Rats; Signal Transduction; Spironolactone; Survival Analysis; Ventricular Dysfunction, Left; Wasting Syndrome | 2014 |
MEDICAL MANAGEMENT OF DILATED CARDIOMYOPATHY IN LIVINGSTONE FRUIT BATS ( PTEROPUS LIVINGSTONII).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Zoo; Cardiomyopathy, Dilated; Cardiotonic Agents; Chiroptera; Diuretics; Female; Furosemide; Imidazolidines; Male; Pyridazines; Spironolactone | 2017 |